PMID- 19005253 OWN - NLM STAT- MEDLINE DCOM- 20090714 LR - 20090402 IS - 1421-9751 (Electronic) IS - 0008-6312 (Linking) VI - 113 IP - 1 DP - 2009 TI - Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy. PG - 72-80 LID - 10.1159/000171069 [doi] AB - OBJECTIVES: To evaluate clinical reinfarction during a 3-year follow-up after randomization to primary angioplasty versus fibrinolysis in anterior and non-anterior ST elevation myocardial infarction (STEMI). METHODS: Clinical reinfarction was prospectively assessed by an endpoint committee blinded to the study treatment. RESULTS: At 30 days, primary angioplasty compared with fibrinolysis reduced the reinfarction rate both in anterior STEMI patients (n = 823; 2.5 vs. 5.6%, p = 0.02) and in non-anterior STEMI patients (n = 743; 0.8 vs. 7.4%, p < 0.001). After 3 years, the reduction in reinfarction rate was no longer present in anterior STEMI patients (11.2 vs. 11.2%, p = 0.86), but persisted in non-anterior STEMI patients (5.2 vs. 13.5%, p < 0.001). Reinfarction after anterior STEMI carried a higher mortality than reinfarction after non-anterior STEMI (37.6 vs. 15.3%, p = 0.01). Independent predictors of death were: age [hazard ratio (HR) per 1-year increase in age = 1.08 (1.07-1.09)], clinical reinfarction [HR = 5.15 (3.57-7.43)], anterior index STEMI [HR = 1.65 (1.24-2.19)], and Killip class > or =2 [HR = 1.42 (1.01-2.00)]. The additional late reinfarctions after angioplasty for anterior STEMI were located within the angioplasty-treated target segment. Anterior STEMI patients had smaller mean target vessel diameter, which was associated with reinfarction. CONCLUSIONS: Clinical reinfarction is an independent predictor of death. The early superiority of primary angioplasty over fibrinolysis on reinfarction rate after anterior STEMI diminished during long-term follow-up. CI - Copyright 2008 S. Karger AG, Basel. FAU - Busk, Martin AU - Busk M AD - Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark. FAU - Kristensen, Steen D AU - Kristensen SD FAU - Rasmussen, Klaus AU - Rasmussen K FAU - Kelbaek, Henning AU - Kelbaek H FAU - Thayssen, Per AU - Thayssen P FAU - Madsen, Jan K AU - Madsen JK FAU - Abildgaard, Ulrik AU - Abildgaard U FAU - Krusell, Lars R AU - Krusell LR FAU - Mortensen, Leif S AU - Mortensen LS FAU - Thuesen, Leif AU - Thuesen L FAU - Andersen, Henning R AU - Andersen HR FAU - Nielsen, Torsten T AU - Nielsen TT CN - DANAMI-2 Investigators LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081113 PL - Switzerland TA - Cardiology JT - Cardiology JID - 1266406 SB - IM MH - Aged MH - Denmark/epidemiology MH - Female MH - Follow-Up Studies MH - Humans MH - Male MH - Middle Aged MH - Multicenter Studies as Topic MH - Myocardial Infarction/*etiology/mortality/pathology MH - Myocardial Reperfusion/*methods MH - Myocardium/*pathology MH - Randomized Controlled Trials as Topic MH - Recurrence EDAT- 2008/11/14 09:00 MHDA- 2009/07/15 09:00 CRDT- 2008/11/14 09:00 PHST- 2008/03/05 00:00 [received] PHST- 2008/06/06 00:00 [accepted] PHST- 2008/11/14 09:00 [pubmed] PHST- 2009/07/15 09:00 [medline] PHST- 2008/11/14 09:00 [entrez] AID - 000171069 [pii] AID - 10.1159/000171069 [doi] PST - ppublish SO - Cardiology. 2009;113(1):72-80. doi: 10.1159/000171069. Epub 2008 Nov 13.